Seroprevalence of SARS-CoV-2 Antibodies and Factors Associated with Seropositivity at the University of Salamanca: The DIANCUSAL Study

被引:3
|
作者
Muro, Antonio [1 ]
Belhassen-Garcia, Moncef [1 ]
Munoz Bellido, Juan Luis [2 ,3 ,4 ]
Lorenzo Juanes, Helena [2 ,3 ,4 ]
Vicente, Belen [1 ]
Pendones, Josue [2 ,3 ,4 ]
Adserias, Jose [5 ]
Sanchez Hernandez, Gonzalo [6 ]
Rodriguez Rosa, Miguel [7 ]
Vicente Villardon, Jose Luis [7 ]
Burguillo, Javier [8 ]
Lopez Andaluz, Javier [9 ]
Martin Oterino, Jose Angel [2 ,10 ]
Garcia Criado, Francisco Javier [2 ]
Barbero, Fausto [9 ]
Morales, Ana Isabel [2 ,11 ]
Galindo Villardon, Purificacion
Gonzalez Sarmiento, Rogelio [2 ,12 ]
机构
[1] Univ Salamanca, Infect & Trop Dis Grp e INTRO, Inst Biomed Res Salamanca Res Ctr Trop Dis Un, Fac Pharm, Salamanca 37008, Spain
[2] Univ Salamanca, Inst Biomed Res Salamanca IBSAL, Univ Hosp Salamanca, Salamanca 37007, Spain
[3] Univ Hosp Salamanca, Microbiol & Parasitol Serv, Salamanca 37007, Spain
[4] Univ Salamanca, Dept Biomed & Diagnost Sci, Salamanca 37008, Spain
[5] Univ Salamanca, Univ Salamanca Fdn FGUSAL, IT Dept, Salamanca 37008, Spain
[6] Univ Salamanca, Data Proc Ctr CPD, Salamanca 37008, Spain
[7] Univ Salamanca, Dept Stat, Salamanca 37008, Spain
[8] Univ Salamanca, Fac Pharm, Dept Chem Phys, Salamanca 37008, Spain
[9] Univ Salamanca, Dept Nursing & Phisiotherapy, Salamanca 37008, Spain
[10] Univ Hosp Salamanca, Dept Internal Med, Fac Med, Salamanca 37008, Spain
[11] Univ Salamanca, Toxicol Unit, Salamanca 37008, Spain
[12] Univ Salamanca, Dept Med, Mol Med Unit, Salamanca 37008, Spain
关键词
SARS-CoV-2; COVID-19; antibodies; seroprevalence; screening; university; Salamanca; Spain;
D O I
10.3390/jcm10153214
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Systematic screening for antibodies against SARS-CoV-2 is a crucial tool for surveillance of the COVID-19 pandemic. The University of Salamanca (USAL) in Spain designed a project called "DIANCUSAL" (Diagnosis of New Coronavirus, COVID-19, in University of Salamanca) to measure antibodies against SARS-CoV-2 among its similar to 34,000 students and academic staff, as the influence of the university community in the spread of the SARS-CoV-2 pandemic in the city of Salamanca and neighboring towns hosting USAL campuses could be substantial. Objective: The aim of this study was to estimate the prevalence of SARS-CoV-2 antibodies among USAL students, professors and staff and to evaluate the demographic, academic, clinical and lifestyle and behavioral factors related to seropositivity. Methodology: The DIANCUSAL study is an ongoing university population-based cross-sectional study, with the work described herein conducted from July-October 2020. All USAL students, professors and staff were invited to complete an anonymized questionnaire. Seroprevalence of anti-SARS-CoV-2 antibodies was detected and quantified by using chemiluminescent assays for IgG and IgM. Principal findings: A total of 8197 (24.71%) participants were included. The mean age was 31.4 (14.5 SD) years, and 66.0% of the participants were female. The seroprevalence was 8.25% overall and was highest for students from the education campus (12.5%) and professors from the biomedical campus (12.6%), with significant differences among faculties (p = 0.006). Based on the questionnaire, loss of smell and fever were the symptoms most strongly associated with seropositivity, and 22.6% of seropositive participants were asymptomatic. Social distancing was the most effective hygiene measure (p = 0.0007). There were significant differences in seroprevalence between participants with and without household exposure to SARS-CoV-2 (p = 0.0000), but not between students who lived in private homes and those who lived in dormitories. IgG antibodies decreased over time in the participants with confirmed self-reported COVID-19 diagnoses. Conclusions: The analysis revealed an overall 8.25% seroprevalence at the end of October 2020, with a higher seroprevalence in students than in staff. Thus, there is no need for tailored measures for the USAL community as the official average seroprevalence in the area was similar (7.8% at 22 June and 12.4 at 15 November of 2020). Instead, USAL members should comply with public health measures.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] SARS-CoV-2 Seroprevalence: Demographic and Behavioral Factors Associated With Seropositivity Among College Students in a University Setting
    Diepstra, Karen
    Bullington, Brooke W.
    Premkumar, Lakshmanane
    Shook-Sa, Bonnie E.
    Jones, Corbin
    Pettifor, Audrey
    JOURNAL OF ADOLESCENT HEALTH, 2022, 71 (05) : 559 - 569
  • [2] Seroprevalence of SARS-CoV-2 antibodies and associated risk factors during the second wave of infection in a university community in Cameroon
    Essomba, Rene Ghislain
    Bayibeki, Albert Ngano
    Lissom, Abel
    Ateba, Pulcherie Therese
    Seni, Nassif
    Fouda, Claude Ariane Nlozoa
    Mbitock, Solange Berthe Diwandja
    Ebonda, Normand David
    Afana, Sylvie Delphine
    Akame, Simeon
    Tembu, Adelphe Anyang
    Ngamaleu, Modeste Romuald
    Bimai, Bernard Christel Bihonba
    Kabo, Ousmane
    Nguwoh, Philipe Salomon
    Ngounouh, Christian Taheu
    Meka, Moise Christian Junior
    Kengne, Michel
    Likeng, Julienne-Louise Ngo
    Kimessoukie, Etienne Omolomo
    Nkoum, Benjamin Alexandre
    Assoumou, Marie Claire Okomo
    Fokam, Joseph
    Boum, I. I. Yap
    Ambomo, Myriam Sylvie
    Chadou, Michael Junior Piameu
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2023, 17 (11)
  • [3] SEROPREVALENCE OF SARS-COV-2 ANTIBODIES IN LOW-INCOME UNIVERSITY STUDENTS
    de Souza Araujo, Adriano Antunes
    Quintans-Junior, Lucindo Jose
    Schimieguel, Dulce Marta
    Correa, Cristiane Bani
    de Moura, Tatiana Rodrigues
    Marques Cavalcante, Rafael Ciro
    Grespan, Renata
    Cerqueira-Meneses, Daniele de Vasconcelos
    Barreto-Alves, Jose Antonio
    Martins-Filho, Paulo Ricardo
    EXCLI JOURNAL, 2021, 20 : 276 - 280
  • [4] Seroprevalence of SARS-CoV-2 antibodies in South Korea
    Lee, Kwangmin
    Jo, Seongil
    Lee, Jaeyong
    JOURNAL OF THE KOREAN STATISTICAL SOCIETY, 2021, 50 (03) : 891 - 904
  • [5] Seroprevalence of SARS-CoV-2 antibodies in South Korea
    Kwangmin Lee
    Seongil Jo
    Jaeyong Lee
    Journal of the Korean Statistical Society, 2021, 50 : 891 - 904
  • [6] Estimation of world seroprevalence of SARS-CoV-2 antibodies
    Lee, Kwangmin
    Kim, Seongmin
    Jo, Seongil
    Lee, Jaeyong
    JOURNAL OF APPLIED STATISTICS, 2024, 51 (15) : 3039 - 3058
  • [7] Kinetics and seroprevalence of SARS-CoV-2 antibodies in children
    Roarty, Cathal
    Tonry, Claire
    McFetridge, Lisa
    Mitchell, Hannah
    Watson, Chris
    Waterfield, Thomas
    LANCET INFECTIOUS DISEASES, 2021, 21 (06): : E143 - E143
  • [8] Bayesian estimation of the seroprevalence of antibodies to SARS-CoV-2
    Dong, Qunfeng
    Gao, Xiang
    JAMIA OPEN, 2020, 3 (04) : 496 - 499
  • [9] Seroprevalence of antibodies to SARS-CoV-2 and predictors of seropositivity among employees of a teaching hospital in New Delhi, India
    Sharma, Pragya
    Chawla, Rohit
    Bakshi, Ritika
    Saxena, Sonal
    Basu, Saurav
    Bharti, Pradeep Kumar
    Dhuria, Meera
    Singh, S. K.
    Lal, Panna
    OSONG PUBLIC HEALTH AND RESEARCH PERSPECTIVES, 2021, 12 (02) : 88 - 95
  • [10] Seroprevalence of SARS-CoV-2 antibodies in children: a prospective multicentre cohort study
    Waterfield, Thomas
    Watson, Chris
    Moore, Rebecca
    Ferris, Kathryn
    Tonry, Claire
    Watt, Alison
    McGinn, Claire
    Foster, Steven
    Evans, Jennifer
    Lyttle, Mark David
    Ahmad, Shazaad
    Ladhani, Shamez
    Corr, Michael
    McFetridge, Lisa
    Mitchell, Hannah
    Brown, Kevin
    Amirthalingam, Gayatri
    Maney, Julie-Ann
    Christie, Sharon
    ARCHIVES OF DISEASE IN CHILDHOOD, 2021, 106 (07) : 680 - 685